Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
Busard CI, Cohen AD, Wolf P, Gkalpakiotis S, Cazzaniga S, Stern RS, Hutten BA, Feldhamer I, Quehenberger F, Lichem R, Kojanova M, Adenubiova E, Addis A, Naldi L, Spuls PI. Busard CI, et al. Among authors: kojanova m. J Eur Acad Dermatol Venereol. 2018 Feb;32(2):245-253. doi: 10.1111/jdv.14583. Epub 2017 Oct 17. J Eur Acad Dermatol Venereol. 2018. PMID: 28898541
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic.
Gkalpakiotis S, Cetkovska P, Arenberger P, Dolezal T, Arenbergerova M, Velackova B, Fialova J, Kojanova M; BIOREP study group. Gkalpakiotis S, et al. Among authors: kojanova m. Dermatol Ther (Heidelb). 2021 Aug;11(4):1345-1355. doi: 10.1007/s13555-021-00556-2. Epub 2021 Jun 5. Dermatol Ther (Heidelb). 2021. PMID: 34089479 Free PMC article.
Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic.
Tánczosová M, Kojanová M, Arenbergerová M, Arenberger P, Doležal T, Štrosová D, Fialová J, Gkalpakiotis S. Tánczosová M, et al. Among authors: kojanova m. Cent Eur J Public Health. 2022 Mar;30(1):46-50. doi: 10.21101/cejph.a6885. Cent Eur J Public Health. 2022. PMID: 35421298 Free article.
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry.
Kojanova M, Hugo J, Velackova B, Cetkovska P, Fialova J, Dolezal T, Tichy M, Gkalpakiotis S; BIOREP study group. Kojanova M, et al. J Dermatolog Treat. 2022 Sep;33(6):2827-2837. doi: 10.1080/09546634.2022.2082354. Epub 2022 May 29. J Dermatolog Treat. 2022. PMID: 35635185
23 results